Deferoxamine postischemic cardiac function hypertrophied hearts Myocardial hypertrophy well-recognized risk factor congenital cardiac surgery hearts vulnerability injury effects iron chelator hydroxyl radical scavenger early reperfusion model isolated retroperfused rabbit hearts hypertrophic aortic early life week age rabbits weeks age hearts minutes degrees ischemia minutes reperfusion Postischemic recovery isovolumic developed pressure intracavitary balloon untreated deferoxamine-treated groups normal age-matched controls Deferoxamine mumol/kg group hypertrophied hearts first minutes reperfusion left ventricular weight/body ratio hypertrophied hearts versus age-matched controls Postischemic peak pressure preischemic value normal hearts minutes reperfusion untreated deferoxamine-treated hearts control chronic hypertrophy early life leads susceptibility iron chelator deferoxamine effective injury reperfusion hypertrophied hearts 